1. Home
  2. INSG vs MDXH Comparison

INSG vs MDXH Comparison

Compare INSG & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$9.83

Market Cap

174.9M

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.42

Market Cap

183.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSG
MDXH
Founded
1996
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
174.9M
183.4M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
INSG
MDXH
Price
$9.83
$3.42
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$15.33
$7.67
AVG Volume (30 Days)
159.6K
123.5K
Earning Date
02-19-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$165,876,000.00
$103,069,000.00
Revenue This Year
N/A
$23.34
Revenue Next Year
$14.34
$22.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.68
52 Week Low
$6.24
$1.35
52 Week High
$18.11
$5.33

Technical Indicators

Market Signals
Indicator
INSG
MDXH
Relative Strength Index (RSI) 38.89 44.64
Support Level $9.16 $3.45
Resistance Level $11.14 $3.80
Average True Range (ATR) 0.73 0.20
MACD -0.09 -0.02
Stochastic Oscillator 23.35 5.00

Price Performance

Historical Comparison
INSG
MDXH

About INSG Inseego Corp.

Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: